-transparent.png){kind=logo}
Inhibition of 11 beta-hydroxylase activity was observed to be due to the interaction of adriamycin with adrenal cortex mitochondria. The inhibition of the enzyme was uncompetitive, with an apparent Ki of 100 microM, and was dependent upon the concentration of the drug and the time of incubation. Adriamycin increased the oxygen consumption of these mitochondria. EPR studies showed that adriamycin was reduced to a free radical semiquinone which served to shuttle electrons to oxygen, leading to an impairment in the reduction of cytochrome P450. It is suggested this may be the mechanism for the inhibitory effect of the drug on 11 beta-hydroxylase activity.
Related Publications
A Cuéllar, and
E Escamilla, and
J Ramírez, and
E Chávez
July 1964,
Nature,
A Cuéllar, and
E Escamilla, and
J Ramírez, and
E Chávez
August 1993,
Clinical endocrinology,
A Cuéllar, and
E Escamilla, and
J Ramírez, and
E Chávez
November 1993,
The Journal of endocrinology,
A Cuéllar, and
E Escamilla, and
J Ramírez, and
E Chávez
September 1990,
Steroids,
A Cuéllar, and
E Escamilla, and
J Ramírez, and
E Chávez
March 1970,
Endocrinology,
A Cuéllar, and
E Escamilla, and
J Ramírez, and
E Chávez
December 1961,
Minerva pediatrica,
A Cuéllar, and
E Escamilla, and
J Ramírez, and
E Chávez
October 1969,
FEBS letters,
A Cuéllar, and
E Escamilla, and
J Ramírez, and
E Chávez
January 1967,
Clinical pharmacology and therapeutics,
A Cuéllar, and
E Escamilla, and
J Ramírez, and
E Chávez
October 1987,
Journal of steroid biochemistry,
A Cuéllar, and
E Escamilla, and
J Ramírez, and
E Chávez
December 1964,
Nihon Naibunpi Gakkai zasshi,
